Pfizer to acquire oncology specialist Medivation for $ 14 bn

American global pharmaceutical major Pfizer Inc has entered into an agreement to acquire Medivation Inc, a biopharmaceutical company focused on developing and commercialising small molecules for oncology, for a total enterprise value of approximately $ 14 billion.

The merger will give a boost to Pfizer’s consolidation effort through a series of acquisitions, especially after its bid to take over Allergan Plc in a $150 billion deal late last year fell apart when the Obama administration prevented the proposed combination with new rules.

So let’s do:
1. Pfizer to acquire oncology specialist Medivation for ____. 

Source – The Hindu





Leave a comment

Your email address will not be published. Required fields are marked *